Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B1 | P15538 | 1/20 | 0.33 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.33 |
| ▸ | HTR2A | P28223 | 2/20 | 0.32 |
| ▸ | TP53 | P04637 | 2/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.30 |
| ▸ | DRD2 | P14416 | 1/20 | 0.30 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.30 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.30 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.30 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.30 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.30 |
| ▸ | HTR2C | P28335 | 1/20 | 0.30 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.30 |
| ▸ | HRH1 | P35367 | 1/20 | 0.30 |
| ▸ | DRD3 | P35462 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9859805 | 0.83 | HTR2A (0.34) | HTR2ATP53KDM4ELMNACHRM2 | |
| SCHEMBL4004558 | 0.83 | HTR2A (0.34) | HTR2A | |
| SCHEMBL29213166 | 0.81 | BCHE (0.35) | CYP11B1CYP11B2HTR2ATP53KDM4E | |
| SCHEMBL9860029 | 0.79 | HTR2A (0.32) | HTR2ATP53KDM4ELMNACHRM2 | |
| SCHEMBL27372929 | 0.79 | CYP11B1 (0.33) | CYP11B1CYP11B2HTR2ATP53KDM4E | |
| SCHEMBL6344924 | 0.79 | DRD2 (0.38) | CYP11B1CYP11B2HTR2ATP53KDM4E | |
| SCHEMBL5090003 | 0.79 | — | — | |
| SCHEMBL1453949 | 0.79 | CYP11B1 (0.33) | CYP11B1CYP11B2 | |
| SCHEMBL31087274 | 0.79 | — | — | |
| SCHEMBL7919016 | 0.78 | KDM4E (0.33) | CYP11B1CYP11B2HTR2ATP53KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7081543-B2 | Bridged biscyclopentadienyl ligands and method of preparation | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2006-07-25 | — | — | US | claimed |
| US-20050250956-A1 | Bridged biscyclopentadienyl ligands and method of preparation | RIX FRANCIS C | 2005-11-10 | — | — | US | claimed |
| US-6960676-B2 | Method of preparing group 14 bridged biscyclopentadienyl ligands | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2005-11-01 | — | — | US | claimed |
| EP-1263764-B1 | METHOD OF PREPARING GROUP 14 BRIDGED BISCYCLOPENTADIENYL LIGANDS | EXXONMOBIL CHEM PATENTS INC (US) | 2004-04-14 | — | — | EP | claimed |
| US-20030220190-A1 | Method of preparing group 14 bridged biscyclopentadienyl ligands | EXXONMOBIL CHEMICAL PATENTS INC. | 2003-11-27 | — | — | US | claimed |
| CN-1406241-A | Method of preparing group 14 bridged biscyclopentadienyl ligands | EXXON MOBILE CHEMICAL PATENTS (US) | 2003-03-26 | — | — | CN | claimed |
| EP-1263764-A1 | METHOD OF PREPARING GROUP 14 BRIDGED BISCYCLOPENTADIENYL LIGANDS | ExxonMobil Chemical Patents Inc. (US) | 2002-12-11 | — | — | EP | claimed |
| WO-2001058913-A1 | METHOD OF PREPARING GROUP 14 BRIDGED BISCYCLOPENTADIENYL LIGANDS | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2001-08-16 | — | — | WO | claimed |
| US-10040883-B2 | Multimodal polyolefin resin and molded product prepared therefrom | DAELIM INDUSTRIAL CO., LTD. (KR) | 2018-08-07 | — | — | US | disclosed |
| CN-104203996-B | Multimodal polyolefin resin and formed body prepared therefrom | 大林产业株式会社 | 2018-04-20 | — | — | CN | disclosed |
| EP-2832753-B1 | MULTIMODAL POLYOLEFIN RESIN AND MOLDED PRODUCT PREPARED THEREFROM | DAELIM IND CO LTD (KR) | 2018-04-11 | — | — | EP | disclosed |
| EP-2832753-A1 | MULTIMODAL POLYOLEFIN RESIN AND MOLDED PRODUCT PREPARED THEREFROM | Daelim Industrial Co., Ltd. (KR) | 2015-02-04 | — | — | EP | disclosed |
| CN-104203996-A | Multimodal polyolefin resin and molded product prepared therefrom | DAELIM IND CO LTD | 2014-12-10 | — | — | CN | disclosed |
| US-20130345375-A1 | OLEFIN POLYMERIZATION CATALYST COMPOSITION AND OLEFIN POLYMERIZATION PROCESS USING THE SAME | DAELIM INDUSTRIAL CO., LTD. (KR) | 2013-12-26 | — | — | US | disclosed |
| US-6960676-B2 | Method of preparing group 14 bridged biscyclopentadienyl ligands | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2005-11-01 | — | — | US | disclosed |
| EP-1263764-B1 | METHOD OF PREPARING GROUP 14 BRIDGED BISCYCLOPENTADIENYL LIGANDS | EXXONMOBIL CHEM PATENTS INC (US) | 2004-04-14 | — | — | EP | disclosed |
| US-20030220190-A1 | Method of preparing group 14 bridged biscyclopentadienyl ligands | EXXONMOBIL CHEMICAL PATENTS INC. | 2003-11-27 | — | — | US | disclosed |
| CN-1406241-A | Method of preparing group 14 bridged biscyclopentadienyl ligands | EXXON MOBILE CHEMICAL PATENTS (US) | 2003-03-26 | — | — | CN | disclosed |
| EP-1263764-A1 | METHOD OF PREPARING GROUP 14 BRIDGED BISCYCLOPENTADIENYL LIGANDS | ExxonMobil Chemical Patents Inc. (US) | 2002-12-11 | — | — | EP | disclosed |
| WO-2001058913-A1 | METHOD OF PREPARING GROUP 14 BRIDGED BISCYCLOPENTADIENYL LIGANDS | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2001-08-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050250956-A1 | Bridged biscyclopentadienyl ligands and method of preparation | FDPS, PPIP5K2, DBF4 | CYP11B1 1045/4885CYP11B2 1128/4885HTR2A 4439/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.